Regulation of apoptosis-related genes by nitric oxide in cancer

Nitric Oxide - Biology and Chemistry

Volumn 19, Issue 2, 2008, Pages 170-176

  Olson, Samuel Y ^a   Garbán, Hermes J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; FOXP3; Gene expression; NF B; Nitric oxide; p53; Reactive nitrogen species; S nitrosylation; Transcription factors; Transcriptional regulation; YY1

Indexed keywords

CYCLIC GMP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR YY1;

APOPTOSIS; CANCER CELL; CANCER GENETICS; CELL SURVIVAL; GENE CONTROL; GENE DISRUPTION; GENE EXPRESSION; GENE REPRESSION; HUMAN; NITROSYLATION; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

APOPTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; NITRIC OXIDE;

EID: 47049131349     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2008.04.005     Document Type: Review

References (101)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. Faseb J. 6 (1992) 3051-3064
2. Nathan C., and Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269 (1994) 13725-13728
3. Mayer B., and Hemmens B. Biosynthesis and action of nitric oxide in mammalian cells [published erratum appears in Trends Biochem Sci 1998 Feb;23(2):87]. Trends Biochem. Sci. 22 (1997) 477-481
4. Knowles R.G., and Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298 (1994) 249-258
5. Xie Q., and Nathan C. The high-output nitric oxide pathway: role and regulation. J. Leukoc. Biol. 56 (1994) 576-582
6. Schmidt H.H., and Walter U. NO at work. Cell 78 (1994) 919-925
7. Geller D.A., Nussler A.K., Di Silvio M., Lowenstein C.J., Shapiro R.A., Wang S.C., Simmons R.L., and Billiar T.R. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc. Natl. Acad. Sci. USA 90 (1993) 522-526
8. Sherman P.A., Laubach V.E., Reep B.R., and Wood E.R. Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32 (1993) 11600-11605
9. Hokari A., Zeniya M., and Esumi H. Cloning and functional expression of human inducible nitric oxide synthase (NOS) cDNA from a glioblastoma cell line A-172. J. Biochem. (Tokyo) 116 (1994) 575-581
10. Langrehr J.M., Hoffman R.A., Lancaster Jr. J.R., and Simmons R.L. Nitric oxide-a new endogenous immunomodulator. Transplantation 55 (1993) 1205-1212
11. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
12. Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., and Moncada S. Roles of nitric oxide in tumor growth. Proc. Natl. Acad. Sci. USA 92 (1995) 4392-4396
13. Liu L., and Stamler J.S. NO: an inhibitor of cell death. Cell Death Differ. 6 (1999) 937-942
14. Liu H., Sidiropoulos P., Song G., Pagliari L.J., Birrer M.J., Stein B., Anrather J., and Pope R.M. TNF-alpha gene expression in macrophages: regulation by NF-kappa B is independent of c-Jun or C/EBP beta. J. Immunol. 164 (2000) 4277-4285
15. Shi Y., Lee J.S., and Galvin K.M. Everything you have ever wanted to know about Yin Yang 1. Biochim. Biophys. Acta 1332 (1997) F49-F66
16. Andrew P.J., Harant H., and Lindley I.J. Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214 (1995) 949-956
17. Andrew P.J., Harant H., and Lindley I.J. Up-regulation of interleukin-1beta-stimulated interleukin-8 in human keratinocytes by nitric oxide. Biochem. Pharmacol. 57 (1999) 1423-1429
18. Chang R.H., Feng M.H., Liu W.H., and Lai M.Z. Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90 (1997) 364-369
19. Fowler III A.A., Fisher B.J., Sweeney L.B., Wallace T.J., Natarajan R., Ghosh S.S., and Ghosh S. Nitric oxide regulates interleukin-8 gene expression in activated endothelium by inhibiting NF-kappaB binding to DNA: effects on endothelial function. Biochem. Cell Biol. 77 (1999) 201-208
20. Frank S., Kampfer H., Podda M., Kaufmann R., and Pfeilschifter J. Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation. Biochem. J. 346 Pt. 3 (2000) 719-728
21. Kallmann B.A., Malzkorn R., and Kolb H. Exogenous nitric oxide modulates cytokine production in human leukocytes. Life Sci. 65 (1999) 1787-1794
22. Rothe H., Hartmann B., Geerlings P., and Kolb H. Interleukin-12 gene-expression of macrophages is regulated by nitric oxide. Biochem. Biophys. Res. Commun. 224 (1996) 159-163
23. Kroncke K.D., and Carlberg C. Inactivation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide. Faseb J. 14 (2000) 166-173
24. Shinyashiki M., Chiang K.T., Switzer C.H., Gralla E.B., Valentine J.S., Thiele D.J., and Fukuto J.M. The interaction of nitric oxide (NO) with the yeast transcription factor Ace1: a model system for NO-protein thiol interactions with implications to metal metabolism. Proc. Natl. Acad. Sci. USA 97 (2000) 2491-2496
25. Stamler J.S. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr. Top. Microbiol. Immunol. 196 (1995) 19-36
26. Stamler J.S., and Hausladen A. Oxidative modifications in nitrosative stress [news; comment]. Nat. Struct. Biol. 5 (1998) 247-249
27. Gitler C., Zarmi B., and Kalef E. General method to identify and enrich vicinal thiol proteins present in intact cells in the oxidized, disulfide state. Anal. Biochem. 252 (1997) 48-55
28. Peng H.B., Rajavashisth T.B., Libby P., and Liao J.K. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 270 (1995) 17050-17055
29. Tabuchi A., Sano K., Oh E., Tsuchiya T., and Tsuda M. Modulation of AP-1 activity by nitric oxide (NO) in vitro: NO-mediated modulation of AP-1. FEBS Lett. 351 (1994) 123-127
30. Tabuchi A., Oh E., Taoka A., Sakurai H., Tsuchiya T., and Tsuda M. Rapid attenuation of AP-1 transcriptional factors associated with nitric oxide (NO)-mediated neuronal cell death. J. Biol. Chem. 271 (1996) 31061-31067
31. Peunova N., and Enikolopov G. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells [published erratum appears in Nature 1993 Sep 30;365(6445):468]. Nature 364 (1993) 450-453
32. Kim H.H., and Kim K. Enhancement of TNF-alpha-mediated cell death in vascular smooth muscle cells through cytochrome c -independent pathway by the proteasome inhibitor. FEBS Lett. 535 (2003) 190-194
33. Fisher D.E. Apoptosis in cancer therapy: crossing the threshold. Cell 78 (1994) 539-542
34. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
35. Martin S.J., and Green D.R. Apoptosis and cancer: the failure of controls on cell death and cell survival. Crit. Rev. Oncol. Hematol. 18 (1995) 137-153
36. Dive C., and Hickman J.A. Drug-target interactions: only the first step in the commitment to a programmed cell death?. Br. J. Cancer 64 (1991) 192-196
37. Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2 (1990) 275-280
38. Frost P., and Bonavida B. Circumvention of tumor cell escape following specific immunotherapy. Cancer Biother. Radiopharm. 15 (2000) 141-152
39. Vaux D.L., and Strasser A. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93 (1996) 2239-2244
40. Blaise G.A., Gauvin D., Gangal M., and Authier S. Nitric oxide, cell signaling and cell death. Toxicology 208 (2005) 177-192
41. Mannick J.B., and Schonhoff C.M. NO means no and yes: regulation of cell signaling by protein nitrosylation. Free Radic. Res. 38 (2004) 1-7
42. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis. Biochem. Biophys. Res. Commun. 282 (2001) 1075-1079
43. Dash P.R., Cartwright J.E., Baker P.N., Johnstone A.P., and Whitley G.S. Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP-dependent mechanism and independently of caspase 3 nitrosylation. Exp. Cell Res. 287 (2003) 314-324
44. Pilz R.B., and Casteel D.E. Regulation of gene expression by cyclic GMP. Circ. Res. 93 (2003) 1034-1046
45. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
46. Golstein P. Cell death: TRAIL and its receptors. Curr. Biol. 7 (1997) R750-R753
47. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
48. Smith C.A., Farrah T., and Goodwin R.G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76 (1994) 959-962
49. Gruss H.J., and Dower S.K. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood 85 (1995) 3378-3404
50. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., and Baldwin Jr. A.S. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation. Science 281 (1998) 1680-1683
51. Garban H.J., and Bonavida B. Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecol. Oncol. 73 (1999) 257-264
52. Morimoto H., Yonehara S., and Bonavida B. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 53 (1993) 2591-2596
53. Fukuo K., Hata S., Suhara T., Nakahashi T., Shinto Y., Tsujimoto Y., Morimoto S., and Ogihara T. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle. Hypertension 27 (1996) 823-826
54. Stassi G., De Maria R., Trucco G., Rudert W., Testi R., Galluzzo A., Giordano C., and Trucco M. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J. Exp. Med. 186 (1997) 1193-1200
55. Rudert F., Visser E., Forbes L., Lindridge E., Wang Y., and Watson J. Identification of a silencer, enhancer, and basal promoter region in the human CD95 (Fas/APO-1) gene. DNA Cell Biol. 14 (1995) 931-937
56. Garban H.J., and Bonavida B. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells. J. Immunol. 167 (2001) 75-81
57. Lee J.Y., Huerta-Yepez S., Vega M., Baritaki S., Spandidos D.A., and Bonavida B. The NO TRAIL to YES TRAIL in cancer therapy (review). Int. J. Oncol. 31 (2007) 685-691
58. Hongo F., Garban H., Huerta-Yepez S., Vega M., Jazirehi A.R., Mizutani Y., Miki T., and Bonavida B. Inhibition of the transcription factor Yin Yang 1 activity by S -nitrosation. Biochem. Biophys. Res. Commun. 336 (2005) 692-701
59. Wang C.Y., Cusack Jr. J.C., Liu R., and Baldwin Jr. A.S. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat. Med. 5 (1999) 412-417
60. Gordon S., Akopyan G., Garban H., and Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25 (2006) 1125-1142
61. Liu Z.G., Hsu H., Goeddel D.V., and Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87 (1996) 565-576
62. Beg A.A., and Baltimore D. An essential role for NF-kB in preventing TNF-alpha-induced cell death. Science 274 (1996) 782-784
63. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., and Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274 (1996) 787-789
64. Wang C.Y., Mayo M.W., and Baldwin Jr. A.S. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB [see comments]. Science 274 (1996) 784-787
65. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl. (2002) S81-S96
66. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
67. Werner S.L., Barken D., and Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 (2005) 1857-1861
68. Park J.M., Greten F.R., Wong A., Westrick R.J., Arthur J.S., Otsu K., Hoffmann A., Montminy M., and Karin M. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity 23 (2005) 319-329
69. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309 (2005) 1854-1857
70. Mayo M.W., and Baldwin A.S. The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta 1470 (2000) M55-M62
71. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227
72. Makris C., Godfrey V.L., Krahn-Senftleben G., Takahashi T., Roberts J.L., Schwarz T., Feng L., Johnson R.S., and Karin M. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol. Cell. 5 (2000) 969-979
73. Hong Y.H., Peng H.B., La Fata V., and Liao J.K. Hydrogen peroxide-mediated transcriptional induction of macrophage colony-stimulating factor by TGF-beta1. J. Immunol. 159 (1997) 2418-2423
74. Schreck R., Albermann K., and Baeuerle P.A. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic. Res. Commun. 17 (1992) 221-237
75. Garcia-Ruiz C., Colell A., Mari M., Morales A., and Fernandez-Checa J.C. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J. Biol. Chem. 272 (1997) 11369-11377
76. Hennet T., Richter C., and Peterhans E. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289 (1993) 587-592
77. Suzuki Y.J., Forman H.J., and Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22 (1997) 269-285
78. Huie R.E., and Padmaja S. The reaction of no with superoxide. Free Radic. Res. Commun. 18 (1993) 195-199
79. Fukuto J.M., and Wink D.A. Nitric oxide (NO): formation and biological roles in mammalian systems. Met. Ions Biol. Syst. 36 (1999) 547-595
80. Szabo C., and Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1 (1997) 373-385
81. Huerta-Yepez S., Vega M., Jazirehi A., Garban H., Hongo F., Cheng G., and Bonavida B. Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-kappa B and inhibition of Bcl-xl expression. Oncogene 23 (2004) 4993-5003
82. Peng H.B., Libby P., and Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270 (1995) 14214-14219
83. DelaTorre A., Schroeder R.A., and Kuo P.C. Alteration of NF-kappa B p50 DNA binding kinetics by S-nitrosylation. Biochem. Biophys. Res. Commun. 238 (1997) 703-706
84. Matthews J.R., Botting C.H., Panico M., Morris H.R., and Hay R.T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 24 (1996) 2236-2242
85. Benchimol S. p53-dependent pathways of apoptosis. Cell Death Differ. 8 (2001) 1049-1051
86. Yu J., Wang Z., Kinzler K.W., Vogelstein B., and Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 1931-1936
87. Rubbi C.P., and Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. Embo J. 22 (2003) 6068-6077
88. Oren M. Decision making by p53: life, death and cancer. Cell Death Differ. 10 (2003) 431-442
89. Haupt S., Louria-Hayon I., and Haupt Y. P53 licensed to kill? Operating the assassin. J. Cell Biochem. 88 (2003) 76-82
90. Vousden K.H. Switching from life to death: the Miz-ing link between Myc and p53. Cancer Cell 2 (2002) 351-352
91. Ishida A., Sasaguri T., Miwa Y., Kosaka C., Taba Y., and Abumiya T. Tumor suppressor p53 but not cGMP mediates NO-induced expression of p21(Waf1/Cip1/Sdi1) in vascular smooth muscle cells. Mol. Pharmacol. 56 (1999) 938-946
92. Tian B., Liu J., Bitterman P.B., and Bache R.J. Mechanisms of cytokine induced NO-mediated cardiac fibroblast apoptosis. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1958-H1967
93. Wang X., Michael D., de Murcia G., and Oren M. p53 Activation by nitric oxide involves down-regulation of Mdm2. J. Biol. Chem. 277 (2002) 15697-15702
94. Hemish J., Nakaya N., Mittal V., and Enikolopov G. Nitric oxide activates diverse signaling pathways to regulate gene expression. J. Biol. Chem. 278 (2003) 42321-42329
95. Kaestner K.H., Knochel W., and Martinez D.E. Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev. 14 (2000) 142-146
96. Kaufmann E., and Knochel W. Five years on the wings of fork head. Mech. Dev. 57 (1996) 3-20
97. Coffer P.J., and Burgering B.M. Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4 (2004) 889-899
98. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
99. Ochs H.D., Ziegler S.F., and Torgerson T.R. FOXP3 acts as a rheostat of the immune response. Immunol. Rev. 203 (2005) 156-164
100. Hahn B.H., Singh R.P., La Cava A., and Ebling F.M. Tolerogenic treatment of lupus mice with consensus peptide induces Foxp3-expressing, apoptosis-resistant, TGFbeta-secreting CD8+ T cell suppressors. J. Immunol. 175 (2005) 7728-7737
101. Garban H.J., Marquez-Garban D.C., Pietras R.J., and Ignarro L.J. Rapid nitric oxide-mediated S-nitrosylation of estrogen receptor: regulation of estrogen-dependent gene transcription. Proc. Natl. Acad. Sci. USA 102 (2005) 2632-2636